Palavras-chave
Risk factors
Intensive care units
Como Citar
Copyright © | Todos os direitos reservados.
A revista detém os direitos autorais exclusivos de publicação deste artigo nos termos da lei 9610/98.
Reprodução parcial
É livre o uso de partes do texto, figuras e questionário do artigo, sendo obrigatória a citação dos autores e revista.
Reprodução total
É expressamente proibida, devendo ser autorizada pela revista.
Resumo
Objective: To identify risk factors for Clostridrioides difficile infection (CDI) in adult patients admitted to intensive care units. Methods: Integrative literature review, carried out by searching the PubMed database, including articles that evaluated risk factors for CDI in patients admitted to intensive care units. The keywords used were “Clostridioides difficile”, “risk factors” and “intensive care units”. Results: The search resulted in 74 articles, 23 were pre-selected for reading and analysis, of which 11 were excluded according to the objective and inclusion criteria, and 12 articles were included. Final considerations: Risk factors for CDI include the use of broad-spectrum antibiotics, prolonged hospitalization, intensive care unit stay, severe illness, advanced age, immunosuppressive therapy, enteral nutrition, proton pump inhibitors, presence of comorbidities and metabolic disorders. Knowledge of these factors is essential for prevention and good therapeutic management of hospitalized patients, especially in intensive care units.
Referências
ANTONELLI M, et al. Clostridioides difficile (formerly Clostridium difficile) infection in the critically ill: an expert statement. Intensive Care MedicineSpringer, 2020; 46(2): 5873.
BALSELLS E, et al. Global burden of Clostridium difficile infections: A systematic review and meta-analysis. Journal of Global Health, 2019; 9(1): 10407.
BLOT S, et al. Healthcare-associated infections in adult intensive care unit patients: Changes in epidemiology, diagnosis, prevention and contributions of new technologies. Intensive and Critical Care Nursing, 2022; 70: 103227.
BUDDLE JE e FAGAN RP. Pathogenicity and virulence of Clostridioides difficile. Virulence Taylor and Francis Ltd, 2023; 10(1): 2150452.
CHAPELA S, et al. Prevalencia de diarrea en pacientes adultos en terapia intensiva y su relación con las fórmulas enterales listas para utilizar. Revista de la Facultad de Ciencias Médicas de Córdoba, 2022; 79(3): 36975.
CUI Y, et al. Risk factors for Clostridioides difficile infection and colonization among patients admitted to an intensive care unit in Shanghai, China. BMC Infectious Diseases, 2019; 19(1): 961.
DEL VECCHIO LE, et al. Risk Factors, Diagnosis, and Management of Clostridioides difficile Infection in Patients with Inflammatory Bowel Disease. Microorganisms, 2022; 10(7): 1315.
FEUERSTADT P, et al. Mortality, Health Care Use, and Costs of Clostridioides difficile Infections in Older Adults. Journal of the American Medical Directors Association, 2022; 23(10): 153.
HEIMANN SM, et al. Economic burden and cost-effective management of Clostridium difficile infections. Medecine et Maladies Infectieuses, 2018; 48(1): 23-29.
KAABIA NM, et al. Epidemiology of Clostridioides difficile infection at a tertiary care facility in Saudi Arabia. Saudi Medical Journal, 2024; 45(2): 188-193.
KARAOUI WR, et al. Incidence, outcome, and risk Incidence, outcome, and risk factors for recurrence of nosocomial Clostridioides difficile infection in adults: A prospective cohort study. Journal of Infection and Public Health, 2020; 13(4): 485–490.
KASSEM S, et al. Clinical outcomes of clostridioides difficile infection in the very elderly. Internal and Emergency Medicine, 2024; 19(4): 1041-1049.
KIM SM, et al. Impact of chronic kidney disease on clinical outcomes in diabetic patients undergoing percutaneous coronary intervention in the era of newer-generation drug-eluting stents. Korean Circulation Journal, 2017; 47(2): 312.
LEE JC, et al. Severe Clostridium difficile infections in intensive care units: Diverse clinical presentations. Journal of Microbiology, Immunology and Infection, 2021; 54(6): 1111–1117.
LESSA FC, et al. Burden of Clostridium difficile Infection in the United States. New England Journal of Medicine, 2015; 372(9): 825–834.
LI C, et al. Incidence and outbreak of healthcare-onset healthcare-associated Clostridioides difficile infections among intensive care patients in a large teaching hospital in China. Frontiers in Microbiology, 2018; 9: 566.
MADA PK e ALAM MU. Clostridioides difficile Infection. StatPearls Publishing, 2023.
MATTHAIOU DK, et al. Characteristics, risk factors and outcomes of Clostridium difficile infections in Greek Intensive Care Units. Intensive and Critical Care Nursing, 2019; 53: 73–78.
MENG X, et al. Antibiotic Resistances and Molecular Characteristics of Clostridioides difficile in ICUs in a Teaching Hospital From Central South China. Frontiers in Medicine, 2021; 8: 745383.
MI H, et al. Colonization of Toxigenic Clostridium difficile Among Intensive Care Unit Patients: A Multi-Centre Cross-Sectional Study. Frontiers in Cellular and Infection Microbiology, 2020; 10: 12.
MOREELS T, et al. Self-Management Interventions for Facilitating Life Participation for Persons with Kidney Failure A Systematic Review. Clinical Journal of the American Society of Nephrology, 2024; 19(2): 189–201.
TAY HL, et al. Risk factors and treatment outcomes of severe Clostridioides difficile infection in Singapore. Scientific Reports,2019; 9(1): 13440.
WANG D, et al. Risk factors and intestinal microbiota: Clostridioides difficile infection in patients receiving enteral nutrition at Intensive Care Units. Critical Care, 2020; 24(1): 426.
WORLEY J, et al. Genomic Determination of Relative Risks for Clostridioides difficile Infection from Asymptomatic Carriage in Intensive Care Unit Patients. Clinical Infectious Diseases, 2021; 73(7): 1727–1736.